The Tata Medical Center is committed to research and development in all aspects of cancer and its management. Our aim is to develop a solid platform for clinical, laboratory and translational research in oncology.
The ambit of research at Tata Medical Center will cover phase I/II/II clinical trials as well as laboratory and technical studies on a wide range of subjects. Collaborative research and developmental activities with some of the best academic hospitals are planned. A memorandum of understanding (MoU) has already been signed with Duke University in the United States for collaboration in a wide range of activities, including clinical research as well as health information technology.
TMC is uniquely equipped for research of the highest standards. The hospital has state of the art infrastructure in all clinical and laboratory departments. Clinical information storage and flow is entirely electronic, with excellent search and retrieval facilities. The faculty has an excellent academic background and research experience. A large fellowship program has been initiated in all departments to foster new research and developmental activities under faculty supervision.
Patient safety is paramount in all clinical studies. All clinical studies involving human subjects will follow a rigorous protocol compliant with international Good Clinical Practice (GCP) norms. All study proposals will be reviewed by an Institutional Review Board (IRB) and an Ethics Committee. A monitoring committee will periodically review progress of clinical studies.